Contact

About
Food Allergies and Our Approach
- Food Allergies Overview
- Our Approach and Platform
Programmes and Clinical Trials
News & Events
- News
- Events
- In the News
Menu Menu

Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

3 June 2026

Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

SnackSafely
3 June 2026

https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png 0 0 Admin https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png Admin2026-06-03 08:00:092026-09-03 13:22:11Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

© Aravax

Contact Us

Email: info@aravax.com.au

Australia

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia
Tel: +61 (0)3 9657 0700

UK

John Eccles House, Oxford Science Park
Oxford, OX4 4GP, United Kingdom

Aravax Future of Allergy Immunotherapy Aravax’s Allergy Shot Gains FDA Fast Track, Fueling Race for a Cure